Biopsy-guided treatment planning for certain head and neck cancers
Part of Cancer clinical trials.
This trial tries a more personalized treatment approach for people with locally advanced head and neck cancers by testing their tumor and blood for cancer “genetic” clues. If you may be eligible, you would have fresh tumor (and possibly lymph node) biopsies at the start and again if the cancer returns, plus blood tests to guide research and future study options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with squamous cell head and neck cancer or nasopharyngeal cancer
- Your cancer is in a specific area (paranasal sinus, nasal cavity, nasopharynx, oral cavity, oropharynx, larynx, or hypopharynx) and is being treated with curative radiation and/or chemoradiotherapy
- You can have fresh biopsy samples taken (from the tumor and/or nearby lymph node) and also have blood drawn for genetic testing
- You must be able to measure/track the cancer on scans (“measurable disease”) and have sufficient organ health for treatment
- You must be willing to share your de-identified genetic and clinical information for national/international research and be contacted for future studies
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
This trial collects tissue and health information to find the best treatment for your head and neck cancer. It may help guide your care by looking at the genetic details of your tumor.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
This study looks for early “biomarkers” (signals in blood or tissue) to see how well head and neck cancer treatments are working over time. It may help doctors adjust treatment sooner based on those early signals.
This study analyzes genetic information from blood samples in patients with advanced lung cancer, head and neck cancer, or mesothelioma who are starting chemotherapy and immunotherapy. Understanding your cancer's genetics may help doctors personalize treatment and improve outcomes.
This trial tests if monitoring cancer DNA left in your blood after surgery can help decide if you need additional treatment. It is for people with HPV-positive oropharynx (throat) cancer who have a certain amount of cancer DNA detected before surgery.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.